Tissue Regenix has achieved a significant milestone, recording its first pre-tax profit, driven primarily by its expanding U.S. operations.The company’s…
Tissue Regenix, a prominent player in regenerative medicine, has strategically acquired CellRight in a groundbreaking £23 million deal. This significant…
